DcR2 anticorps
-
- Antigène Voir toutes DcR2 (TNFRSF10D) Anticorps
- DcR2 (TNFRSF10D) (Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D))
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp DcR2 est non-conjugé
-
Application
- Immunohistochemistry (IHC), Flow Cytometry (FACS), Immunocytochemistry (ICC), Immunoprecipitation (IP)
- Specificité
- Recognizes human TRAIL-R4. Does not cross-react with human TRAIL-R1, -R2 or -R3.
- Pureté
- > 95% (SDS-PAGE)
- Immunogène
- Recombinant human TRAIL-R4 (DcR2).
- Clone
- HS402
- Isotype
- IgG1
- Top Product
- Discover our top product TNFRSF10D Anticorps primaire
-
-
- Indications d'application
- Optimal working dilution should be determined by the investigator.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 mg/mL
- Buffer
- Liquid. In PBS containing 10 % glycerol and 0.02 % sodium azide.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Stable for at least 1 year after receipt when stored at -20°C.
-
- Antigène
- DcR2 (TNFRSF10D) (Tumor Necrosis Factor Receptor Superfamily, Member 10d, Decoy with Truncated Death Domain (TNFRSF10D))
- Autre désignation
- TRAIL-R4 (TNFRSF10D Produits)
- Synonymes
- anticorps TNFRSF10D, anticorps CD264, anticorps DCR2, anticorps TRAIL-R4, anticorps TRAILR4, anticorps TRUNDD, anticorps TNF receptor superfamily member 10d, anticorps tumor necrosis factor receptor superfamily member 10D, anticorps TNFRSF10D, anticorps LOC716901
- Sujet
- TRAIL-R4 is a receptor for the cytotoxic ligand TRAIL. Contains a truncated death domain and hence is not capable of inducing apoptosis. Protects cells against TRAIL mediated apoptosis by competing with TRAIL-R1 and R2 for binding to the ligand.
- ID gène
- 8793
- UniProt
- Q9UBN6
- Pathways
- Apoptose
-